About the Company
We do not have any company description for Klotho Neurosciences, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Klotho Neurosciences, Inc.
Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market
Klotho Neurosciences, Inc. (NASDAQ: KLTO) ("Klotho" or "the Company"), a biotechnology company advancing Klotho-based ...
Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology
Klotho Neurosciences, Inc. (Nasdaq: KLTO), announces that it signed a binding agreement to initiate manufacturing and ...
Klotho Neurosciences, Inc. to Present at Biotech Showcase 2025 on ...
Klotho Neurosciences, Inc. announced that its CEO, Dr. Joseph Sinkule, will present at Biotech Showcase 2025 in San Francisco on January 14, 2025, during J.P. Morgan Healthcare Week.
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs ...
News provided by Klotho Neurosciences, Inc. Jul 25, 2025, 9:05 PM ET Company to Pursue Technologies to Improve Brain Function, Muscle Strength, Bone Health, and Other Longevity Indicators ...
KLOTHO NEUROSCIENCE, INC. ANNOUNCES AN APPROACH TO INCREASE LONGEVITY ...
NEW YORK, June 9, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biogenetics company announced the findings of pre-clinical studies indicating the potential of ...
Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum ...
Klotho Neurosciences, Inc. (NASDAQ: KLTO), is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a protein derived from a patented form ...
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs ...
About Klotho Neurosciences, Inc. Klotho Neurosciences, Inc. (NASDAQ: KLTO), is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a ...
Klotho Neurosciences, Inc. Regains Full Compliance with NASDAQ Minimum ...
--Klotho Neurosciences, Inc., a gene and cell therapy company focused on the treatment of neurodegenerative and other aging-related diseases, today announced that it had received a notification ...
Klotho Neurosciences, Inc. to Expand Development Programs Beyond ... - KTLA
Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology News provided by Klotho Neurosciences, Inc. Jul 24, 2025, 1:30 PM ET ...
UPDATED: Klotho Neurosciences, Inc. to Expand Development ... - KTLA
About Klotho Neurosciences, Inc. Klotho Neurosciences, Inc. (NASDAQ: KLTO), is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using a ...
Similar Companies
Loading the latest forecasts...